American Portfolios Advisors’s Argos Therapeutics, Inc. ARGS Stock Holding History

American Portfolios Advisors’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-50	Closed	-$45	–	2492
2018 Q1	$45	Hold	50	–	–	﹤0.01%	2294
2017 Q4	$150	Buy	+50	New	+$168	﹤0.01%	2234

Other funds holding ARGS

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

American Portfolios Advisors's ARGS Position: Q2 2018 in Review

American Portfolios Advisors sold out of Argos Therapeutics, Inc. (ARGS) in Q2 2018, closing a stake of 50 shares — an estimated $45 sold.

American Portfolios Advisors first reported a position in ARGS in Q4 2017 and held it in 2 quarters. The position peaked at $150 in Q4 2017. 4 funds tracked by Wall St. Rank hold ARGS as of Q2 2018.

American Portfolios Advisors reported no remaining Argos Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
American Portfolios Advisors sold 50 Argos Therapeutics, Inc. shares in Q2 2018, an estimated $45.
American Portfolios Advisors first reported a position in Argos Therapeutics, Inc. in Q4 2017 and held it in 2 quarters.
American Portfolios Advisors's Argos Therapeutics, Inc. position peaked at $150 in Q4 2017.
4 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q2 2018.

Based on American Portfolios Advisors's 13F filing for Q2 2018, filed 24 Mar 2023.